INTRODUCTION: Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder that frequently leads to end-stage renal disease. In this study, we examine the indications, procedures, and outcomes of native nephrectomy (NN) in ADPKD patients at our transplant center. Drawing on 25 years of clinical practice, we aim to provide insights into the surgical management of ADPKD, focusing on the specific factors influencing NN. MATERIALS AND METHODS: A retrospective study was conducted involving ADPKD patients who underwent KT and NN between 1999 and 2023. Collected data encompassed demographics and surgery parameters, such as duration, hospital stay length, blood loss, and complications. Patients were classified based on the urgency (acute/planned) of the NN and its type (unilateral/bilateral), followed by an analysis of the outcomes per group. RESULTS: Out of 152 patients post-KT for ADPKD, 89 (58.6%) underwent NN. The procedures were predominantly unilateral (71; 64%), with bilateral NN accounting for 40 (36%) cases. NN timing relative to KT was 31 (27.9%) pretransplant, 9 (8.1%) concomitant, 51 (45.9%) posttransplant, and 10 (9%) patients undergoing the sandwich technique. Acute NN were performed in 42 cases, while 69 were planned. Acute NNs were associated with longer surgeries, greater blood loss, and a higher incidence of perioperative complications compared to planned NNs. Specifically, unilateral acute NN had a 23.8% complication rate compared to 2.9% in planned cases; bilateral acute NN showed a 28.6% complication rate versus 4.3% in planned cases. CONCLUSION: This investigation accentuates the significance of planning and selection in NN for ADPKD, factoring in the heightened risk of complications. Acute NN are linked to worse outcomes, including higher rates of complications. The data emphasize the necessity of tailored surgical approaches based on individual patient circumstances.

Charles University Faculty of Medicine in Hradec Kralove Hradec Králové Czech Republic

Department of Nephrology University Hospital Hradec Kralove Hradec Králové Czech Republic

Department of Pediatric Surgery and Traumatology University Hospital Hradec Kralove Hradec Králové Czech Republic

Department of Surgery University Hospital Hradec Kralove Hradec Králové Czech Republic

Department of Urology University Hospital Hradec Kralove Sokolska 581 500 05 Hradec Králové Czech Republic

Military Faculty of Medicine Department of Military Surgery University of Defence Hradec Králové Czech Republic

Zobrazit více v PubMed

Levy M, Feingold J (2000) Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int 58(3):925–943. https://doi.org/10.1046/j.1523-1755.2000.00250.x PubMed DOI

Hateboer N, van Dijk MA, Bogdanova N et al (1999) Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 353(9147):103–107. https://doi.org/10.1016/S0140-6736(98)03495-3

Reiterová J (2014) Terapeutické možnosti u polycystické choroby ledvin. Postgraduální Nefrol 12(3):32–35

Chebib FT, Prieto M, Yeonsoon J et al (2015) Native nephrectomy in renal transplant recipients with autosomal-dominant polycystic kidney disease. Transplant Direct 1(10):e43. https://doi.org/10.1097/txd.0000000000000554 PubMed DOI PMC

Dengu F, Azhar B, Pate S, Hakim N (2015) Bilateral nephrectomy for autosomal dominant polycystic kidney disease and timing of kidney transplant: a review of the technical advances in surgical management of autosomal dominant polycystic disease. Exp Clin Transplant 13(3):209–213. https://doi.org/10.6002/ect.2015.0104 PubMed DOI

Sallée M, Rafat C, Zahar J-R et al (2009) Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 4(7):1183–1189. https://doi.org/10.2215/CJN.01870309 PubMed DOI PMC

Fuller TF, Brennan TV, Feng S, Kang S-M, Stock PG, Freise CE (2005) End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation. J Urol 174(6):2284–2288. https://doi.org/10.1097/01.ju.0000181208.06507.aa PubMed DOI

Rozanski J, Kozlowska I, Myslak M et al (2005) Pretransplant nephrectomy in patients with autosomal dominant polycystic kidney disease. Transplant Proc 37(2):666–668. https://doi.org/10.1016/j.transproceed.2004.12.115 PubMed DOI

Nunes P, Mota A, Alves R et al (2007) Simultaneous renal transplantation and native nephrectomy in patients with autosomal-dominant polycystic kidney disease. Transplant Proc 39(8):2483–2485. https://doi.org/10.1016/j.transproceed.2007.07.035 PubMed DOI

Wagner MD, Prather JC, Barry JM (2007) Selective, concurrent bilateral nephrectomies at renal transplantation for autosomal dominant polycystic kidney disease. J Urol 177(6):2250–2254. https://doi.org/10.1016/j.juro.2007.01.146

Cohen D, Timsit M-O, Chrétien Y et al (2008) Place of nephrectomy in patients with autosomal dominant polycystic kidney disease waiting for renal transplantation. Prog Urol 18(10):642–649. https://doi.org/10.1016/j.purol.2008.06.004 PubMed DOI

Kramer A, Sausville J, Haririan A, Bartlett S, Cooper M, Phelan M (2009) Simultaneous bilateral native nephrectomy and living donor renal transplantation are successful for polycystic kidney disease: the University of Maryland experience. J Urol 181(2):724–728. https://doi.org/10.1016/j.juro.2008.10.008 PubMed DOI

Glassman DT, Nipkow L, Bartlett ST, Jacobs SC (2000) Bilateral nephrectomy with concomitant renal graft transplantation for autosomal dominant polycystic kidney disease. J Urol 164(3 Pt 1):661–664. https://doi.org/10.1097/00005392-200009010-00011 PubMed DOI

Bennett AH, Stewart W, Lazarus JM (1973) Bilateral nephrectomy in patients with polycystic renal disease. Surg Gynecol Obstet 137(5):819–820

Mendelssohn DC, Harding ME, Cardella CJ, Cook GT, Uldall PR (1988) Management of end-stage autosomal dominant polycystic kidney disease with hemodialysis and transplantation. Clin Nephrol 30(6):315–319

Guo P, Xu W, Li H, Ren T, Ni S, Ren M (2015) Laparoscopic nephrectomy versus open nephrectomy for patients with autosomal dominant polycystic kidney disease: a systematic review and meta-analysis. PLoS ONE 10(6):e0129317. https://doi.org/10.1371/journal.pone.0129317 PubMed DOI PMC

Argyrou C, Moris D, Vernadakis S (2017) Tailoring the “Perfect Fit” for renal transplant recipients with end-stage polycystic kidney disease: indications and timing of native nephrectomy. In Vivo (Brooklyn) 31(3):307–312. https://doi.org/10.21873/invivo.11060 DOI